The HIV protease is an important drug target for HIV/AIDS therapy, and its structure and function have been extensively investigated. This enzyme performs an essential role in viral maturation by processing specific cleavage sites in the Gag and Gag-Pol precursor polyproteins so as to release their mature forms. This 99 amino acid aspartic protease works as a homodimer, with the active site localized in a central cavity capped by two flexible flap regions. The dimer presents closed or open conformations, which are involved in the substrate binding and release. Here the results of the analysis of a HIV-1 protease data set containing 552 dimer structures are reported. Different dimensionality reduction methods have been used in order to get i...
International audienceHIV protease inhibitors (PIs) approved by the FDA (US Food and Drug Administra...
The flexibility of different regions of HIV-1 protease was examined by using a database consisting o...
AbstractThe crystal structure of HIV-1 protease with an inhibitor has been compared with the structu...
The HIV-1 protease performs essential roles in viral maturation by processing specific cleavage site...
The HIV-1 protease performs essential roles in viral maturation by processing specific cleavage site...
The HIV-1 protease performs essential roles in viral maturation by processing specific cleavage site...
The homodimeric HIV-1 protease is the target of some of the most effective antiviral AIDS therapy, a...
The rational design of drugs that can inhibit the action of viral proteases depends on obtaining acc...
AbstractRetroviral proteases belong to the class of aspartic proteases. A molecular model of HIV-1 p...
The human genome itself operates like a factory. Our body is made up of DNAs, RNAs and mostly protei...
AbstractBackground: The HIV protease is essential for the life cycle of the virus and is an importan...
The dynamics of HIV-1 protease, both in unliganded and substrate-bound forms have been analyzed by u...
Motivation: HIV-1 protease is a key drug target due to its role in the life cycle of the HIV-1 virus...
We present a rigidity analysis on a large number of X-ray crystal structures of the enzyme HIV-1 pro...
<p>Left: Cartoon representation of an unbound (red, pdb ID 3HVP) aligned to a bound receptor structu...
International audienceHIV protease inhibitors (PIs) approved by the FDA (US Food and Drug Administra...
The flexibility of different regions of HIV-1 protease was examined by using a database consisting o...
AbstractThe crystal structure of HIV-1 protease with an inhibitor has been compared with the structu...
The HIV-1 protease performs essential roles in viral maturation by processing specific cleavage site...
The HIV-1 protease performs essential roles in viral maturation by processing specific cleavage site...
The HIV-1 protease performs essential roles in viral maturation by processing specific cleavage site...
The homodimeric HIV-1 protease is the target of some of the most effective antiviral AIDS therapy, a...
The rational design of drugs that can inhibit the action of viral proteases depends on obtaining acc...
AbstractRetroviral proteases belong to the class of aspartic proteases. A molecular model of HIV-1 p...
The human genome itself operates like a factory. Our body is made up of DNAs, RNAs and mostly protei...
AbstractBackground: The HIV protease is essential for the life cycle of the virus and is an importan...
The dynamics of HIV-1 protease, both in unliganded and substrate-bound forms have been analyzed by u...
Motivation: HIV-1 protease is a key drug target due to its role in the life cycle of the HIV-1 virus...
We present a rigidity analysis on a large number of X-ray crystal structures of the enzyme HIV-1 pro...
<p>Left: Cartoon representation of an unbound (red, pdb ID 3HVP) aligned to a bound receptor structu...
International audienceHIV protease inhibitors (PIs) approved by the FDA (US Food and Drug Administra...
The flexibility of different regions of HIV-1 protease was examined by using a database consisting o...
AbstractThe crystal structure of HIV-1 protease with an inhibitor has been compared with the structu...